Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda
- PMID: 28327148
- PMCID: PMC5361791
- DOI: 10.1186/s12936-017-1777-0
Drug resistance mediating Plasmodium falciparum polymorphisms and clinical presentations of parasitaemic children in Uganda
Abstract
Background: Plasmodium falciparum genetic polymorphisms that mediate altered drug sensitivity may impact upon virulence. In a cross-sectional study, Ugandan children with infections mutant at pfcrt K76T, pfmdr1 N86Y, or pfmdr1 D1246Y had about one-fourth the odds of symptomatic malaria compared to those with infections with wild type (WT) sequences. However, results may have been confounded by greater likelihood in those with symptomatic disease of higher density mixed infections and/or recent prior treatment that selected for WT alleles.
Methods: Polymorphisms in samples from paired episodes of asymptomatic and symptomatic parasitaemia in 114 subjects aged 4-11 years were followed longitudinally in Tororo District, Uganda. Paired episodes occurred within 3-12 months of each other and had no treatment for malaria in the prior 60 days. The prevalence of WT, mixed, and mutant alleles was determined using multiplex ligase detection reaction-fluorescent microsphere assays.
Results: Considering paired episodes in the same subject, the odds of symptomatic malaria were lower for infections with mutant compared to WT or mixed sequence at N86Y (OR 0.26, 95% CI 0.09-0.79, p = 0.018), but not K76T or D1246Y. However, symptomatic episodes (which had higher densities) were more likely than asymptomatic to be mixed (for N86Y OR 2.0, 95% CI 1.04-4.0, p = 0.036). Excluding mixed infections, the odds of symptomatic malaria were lower for infections with mutant compared to WT sequence at N86Y (OR 0.33, 95% CI 0.11-0.98, p = 0.046), but not the other alleles. However, if mixed genotypes were grouped with mutants in this analysis or assuming that mixed infections consisted of 50% WT and 50% mutant genotypes, the odds of symptomatic infection did not differ between infections that were mutant or WT at the studied alleles.
Conclusions: Although infections with only the mutant pfmdr1 86Y genotype were associated with symptomatic infection, this association could primarily be explained by greater parasite densities and therefore greater prevalence of mixed infections in symptomatic children. These results indicate limited association between the tested polymorphisms and risk of symptomatic disease and highlight the value of longitudinal studies for assessing associations between parasite factors and clinical outcomes.
Keywords: Drug resistance; Fitness; Malaria; Plasmodium falciparum; Uganda; Virulence.
Similar articles
-
Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda.Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00721-20. doi: 10.1128/AAC.00721-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32660999 Free PMC article.
-
Differential prevalence of transporter polymorphisms in symptomatic and asymptomatic falciparum malaria infections in Uganda.J Infect Dis. 2014 Jul 1;210(1):154-7. doi: 10.1093/infdis/jiu044. Epub 2014 Jan 19. J Infect Dis. 2014. PMID: 24446524 Free PMC article.
-
Validation of the ligase detection reaction fluorescent microsphere assay for the detection of Plasmodium falciparum resistance mediating polymorphisms in Uganda.Malar J. 2014 Mar 14;13:95. doi: 10.1186/1475-2875-13-95. Malar J. 2014. PMID: 24629020 Free PMC article.
-
Asymptomatic falciparum malaria and genetic polymorphisms of Pfcrt K76T and Pfmdr1 N86Y among almajirai in northeast Nigeria.J Infect Dev Ctries. 2015 Mar 31;10(3):290-7. doi: 10.3855/jidc.6853. J Infect Dev Ctries. 2015. PMID: 27031449
-
Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity.Antimicrob Agents Chemother. 2016 Sep 23;60(10):5649-54. doi: 10.1128/AAC.00920-16. Print 2016 Oct. Antimicrob Agents Chemother. 2016. PMID: 27401569 Free PMC article. Clinical Trial.
Cited by
-
Polymorphism analysis of pfmdr1 gene in Plasmodium falciparum isolates 11 years post-adoption of artemisinin-based combination therapy in Saudi Arabia.Sci Rep. 2022 Jan 11;12(1):517. doi: 10.1038/s41598-021-04450-x. Sci Rep. 2022. PMID: 35017593 Free PMC article.
-
Differential Prevalences of Pfmdr1 Polymorphisms in Symptomatic and Asymptomatic Plasmodium falciparum Infections in Lastoursville: A Rural Area in East-Central Gabon.Infect Drug Resist. 2021 Jul 24;14:2873-2882. doi: 10.2147/IDR.S304361. eCollection 2021. Infect Drug Resist. 2021. PMID: 34335033 Free PMC article.
-
Comprehensive analysis of molecular markers linked to antimalarial drug resistance in Plasmodium falciparum in Northern, Northeastern and Eastern Uganda.Malar J. 2025 Jun 13;24(1):190. doi: 10.1186/s12936-025-05439-x. Malar J. 2025. PMID: 40514714 Free PMC article.
-
Associations between Aminoquinoline Resistance Genotypes and Clinical Presentations of Plasmodium falciparum Infection in Uganda.Antimicrob Agents Chemother. 2020 Sep 21;64(10):e00721-20. doi: 10.1128/AAC.00721-20. Print 2020 Sep 21. Antimicrob Agents Chemother. 2020. PMID: 32660999 Free PMC article.
References
-
- World Health Organization . World malaria report 2016. Geneva: World Health Organization; 2016.
-
- Eyase FL, Akala HM, Ingasia L, Cheruiyot A, Omondi A, Okudo C, et al. The role of pfmdr1 and pfcrt in changing chloroquine, amodiaquine, mefloquine and lumefantrine susceptibility in Western-Kenya P. falciparum samples during 2008–2011. PLoS ONE. 2013;8:e64299. doi: 10.1371/journal.pone.0064299. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources